Figure 2.
Cell availability test of B16-F10 after subjecting to different concentrations of apigenin-7-butylene glucoside (∗ implies differences at p<0.005; ∗∗ implies significant differences at p<0.001).
Cell availability test of B16-F10 after subjecting to different concentrations of apigenin-7-butylene glucoside (∗ implies differences at p<0.005; ∗∗ implies significant differences at p<0.001).